We have previously reported that DNA methyltransferase1 (DNMT1) indicates more aggressive tumor growth and resistance to treatment in bladder cancer [23], and the activation of DNMT1 is enhanced by inflammatory cytokines [24]. This evidence concerns the gene DNMT1 and urinary bladder cancer.